ReEngage Therapeutics is a biopharmaceutical company focused on developing drugs that treat longevity-related diseases.
ReEngage Therapeutics has raised $365K in total funding. The most recent round was Seed. The last funding was announced in August 2025.
ReEngage Therapeutics is headquartered in Houston, United States.
ReEngage Therapeutics is a biopharmaceutical company focused on developing drugs that treat longevity-related diseases.
ReEngage Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ReEngage Therapeutics — Funding & Investors." VCBacked, August 6, 2025, https://www.vcbacked.co/company/reengage-therapeutics. Accessed August 15, 2026.
VCBacked. (2025). ReEngage Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/reengage-therapeutics
{{cite web |title=ReEngage Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/reengage-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated